Joanna Bolger

Joanna Bolger is the Vice President and Head of Operations (Development) at MycoMedica Life Sciences. Throughout her nearly 20-year career she has held positions of increasing responsibility in clinical operations and clinical program management. Prior to joining MycoMedica Life Sciences, Ms. Bolger was a Vice President of Clinical Operations at Cortexyme, where she provided oversight and management of the company’s global clinical program in Alzheimer’s Disease. She previously oversaw multiple adult and pediatric programs in oncology and rare metabolic disorders at Fate Therapeutics. Prior to this role, she was the Global Phase 3 Clinical Operations Leader at Cytori Therapeutics, overseeing medical device and biologic (adipose derived stem cell) combo therapy for the treatment of acute myocardial infarction. She has worked as a member of the clinical operations teams at Trius Therapeutics, Phenomix Corporation and Amylin Pharmaceuticals. Ms. Bolger holds a master’s in management and marketing degree and a mechanical engineering degree from the University of Technology in Warsaw (Politechnika Warszawska).